These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 27424981
1. LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway. Xiao C, Wu CH, Hu HZ. Eur Rev Med Pharmacol Sci; 2016 Jul; 20(13):2819-24. PubMed ID: 27424981 [Abstract] [Full Text] [Related]
2. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. Yang Z, Ji L, Jiang G, Liu R, Liu Z, Yang Y, Ma Q, Zhao H. Biosci Trends; 2018 Jul; 12(1):40-46. PubMed ID: 29553100 [Abstract] [Full Text] [Related]
3. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X, Yan W, Dai Z, Gao X, Ma Y, Xu Q, Jiang J, Zhang S. Drug Des Devel Ther; 2016 Jul; 10():1419-41. PubMed ID: 27143851 [Abstract] [Full Text] [Related]
4. The long noncoding RNA HOTTIP promotes breast cancer cell migration, invasiveness, and epithelial-mesenchymal transition via the Wnt-β-catenin signaling pathway. Han S, Jin X, Liu Z, Xing F, Han Y, Yu X, He G, Qiu F. Biochem Cell Biol; 2019 Oct; 97(5):655-664. PubMed ID: 30676763 [Abstract] [Full Text] [Related]
5. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway. Liu H, Wang G, Yang L, Qu J, Yang Z, Zhou X. PLoS One; 2016 Oct; 11(12):e0168406. PubMed ID: 27977766 [Abstract] [Full Text] [Related]
6. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH, Hsu LS, Lin CL, Hong HM, Pan MH, Way TD, Chen WJ. Toxicol Appl Pharmacol; 2013 Nov 01; 272(3):746-56. PubMed ID: 23921149 [Abstract] [Full Text] [Related]
7. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells. Cai K, Jiang L, Wang J, Zhang H, Wang X, Cheng D, Dou J. J Cancer Res Ther; 2014 Nov 01; 10(4):1063-70. PubMed ID: 25579555 [Abstract] [Full Text] [Related]
8. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR. Jiang B, Zhu H, Tang L, Gao T, Zhou Y, Gong F, Tan Y, Xie L, Wu X, Li Y. Anticancer Agents Med Chem; 2022 Nov 01; 22(9):1723-1734. PubMed ID: 33845750 [Abstract] [Full Text] [Related]
9. Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway. Zhang LN, Huang YH, Zhao L. Arch Biochem Biophys; 2019 Nov 15; 676():108137. PubMed ID: 31605677 [Abstract] [Full Text] [Related]
10. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line. Satram-Maharaj T, Nyarko JN, Kuski K, Fehr K, Pennington PR, Truitt L, Freywald A, Lukong KE, Anderson DH, Mousseau DD. Cell Signal; 2014 Dec 15; 26(12):2621-32. PubMed ID: 25152370 [Abstract] [Full Text] [Related]
11. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway. Liu XL, Meng J, Zhang XT, Liang XH, Zhang F, Zhao GR, Zhang T. Thorac Cancer; 2019 Apr 15; 10(4):848-855. PubMed ID: 30810286 [Abstract] [Full Text] [Related]
12. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells. Shan S, Lv Q, Zhao Y, Liu C, Sun Y, Xi K, Xiao J, Li C. Int J Clin Exp Pathol; 2015 Apr 15; 8(10):12357-67. PubMed ID: 26722422 [Abstract] [Full Text] [Related]
13. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling. Geng F, Jiang Z, Song X, Zhou H, Zhao H. Int J Oncol; 2017 Dec 15; 51(6):1898-1908. PubMed ID: 29039479 [Abstract] [Full Text] [Related]
14. Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling. Liu L, Yu D, Shi H, Li J, Meng L. Pharmazie; 2017 Oct 01; 72(10):599-603. PubMed ID: 29441885 [Abstract] [Full Text] [Related]
15. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Jiang YG, Luo Y, He DL, Li X, Zhang LL, Peng T, Li MC, Lin YH. Int J Urol; 2007 Nov 01; 14(11):1034-9. PubMed ID: 17956532 [Abstract] [Full Text] [Related]
16. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway. Hu C, Dong T, Li R, Lu J, Wei X, Liu P. Oncol Rep; 2016 Apr 01; 35(4):2027-34. PubMed ID: 26820690 [Abstract] [Full Text] [Related]
17. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z. Oncogene; 2014 May 22; 33(21):2737-47. PubMed ID: 23752181 [Abstract] [Full Text] [Related]
18. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway. Gao S, Hu J, Wu X, Liang Z. Biomed Pharmacother; 2018 Dec 22; 108():618-624. PubMed ID: 30243096 [Abstract] [Full Text] [Related]
19. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition. Li W, Jia G, Qu Y, Du Q, Liu B, Liu B. Med Sci Monit; 2017 Jul 13; 23():3393-3403. PubMed ID: 28701685 [Abstract] [Full Text] [Related]
20. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer. Li GY, Wang W, Sun JY, Xin B, Zhang X, Wang T, Zhang QF, Yao LB, Han H, Fan DM, Yang AG, Jia LT, Wang L. Theranostics; 2018 Jul 13; 8(10):2846-2861. PubMed ID: 29774079 [Abstract] [Full Text] [Related] Page: [Next] [New Search]